MLKN's YTD underperformance relative to the S&P ( -19.1% vs -27.0%) is the most compelling metric because it demonstrates consistent defensive characteristics across multiple horizons, positioning the stock as a potential re‑rating candidate if market volatility eases.
The five‑year negative return of -19.7% signals that while MLKN outperforms the index, its absolute performance remains weak; a prolonged slowdown in corporate office spend could push cumulative losses deeper, potentially eroding the long‑term compounding benefit and triggering valuation compression.
The overwhelming institutional concentration creates a crowding risk; a coordinated sell‑off by major holders could precipitate a rapid price decline exceeding the historical max drawdown of 38.4%.
The YoY revenue increase of just 1.14% is significant because it barely outpaces inflation, meaning real sales are essentially flat and the company must rely on margin expansion or cost cuts to improve profitability.
The low operating margin of 6.1% translates to $226 M of operating profit on $3.7 B revenue; a 10‑basis‑point deterioration would shave an additional $37 M from earnings, highlighting the fragility of profitability if SG&A costs rise or pricing pressure intensifies.
The most striking profitability finding is the swing to a -1.0% net margin, which turns operating profit into a loss on every $100 of revenue; this erosion directly drives the negative ROE and signals that the company’s core business model is currently unsustainable.
| Year | ROE% | Margin% | Turnover | Leverage | ROIC% | ROCE% | ROA% |
|---|---|---|---|---|---|---|---|
| 2025 | -2.9 | -1.0 | 0.93 | 3.10 | 7.1 | 6.9 | -0.9 |
| 2024 | 5.9 | 2.3 | 0.90 | 2.92 | 6.7 | 6.4 | 2.0 |
| 2023 | 2.9 | 1.0 | 0.96 | 2.98 | 6.3 | 6.0 | 1.0 |
| 2022 | -1.9 | -0.7 | 0.88 | 3.16 | 1.1 | 1.1 | -0.6 |
| 2021 | 20.6 | 7.1 | 1.20 | 2.43 | 15.3 | 14.7 | 8.5 |
| 2020 | -2.2 | -0.6 | 1.22 | 3.18 | 23.3 | 22.5 | -0.7 |
| 2019 | 22.3 | 6.3 | 1.64 | 2.18 | 21.7 | 19.0 | 10.2 |
| 2018 | 19.3 | 5.4 | 1.61 | 2.23 | 18.7 | 17.3 | 8.7 |
| 2017 | 21.1 | 5.4 | 1.74 | 2.22 | 24.0 | 22.1 | 9.5 |
| 2016 | 26.1 | 6.0 | 1.83 | 2.36 | 26.1 | 25.0 | 11.1 |
| 2015 | 22.8 | 4.6 | 1.80 | 2.78 | 22.2 | 21.3 | 8.2 |
A key efficiency risk is the expanding cash conversion cycle; at 66 days, each additional day ties up roughly $5 million in working capital (based on average daily sales), which could strain liquidity if sales do not rebound.
| Year | Total Asset Days | Inventory Days | Receivables Days | Fixed Asset Days | Payables Days | Cash Conversion Cycle |
|---|---|---|---|---|---|---|
| 2025 | 393 | 73 | 38 | 90 | 44 | 66 |
| 2024 | 407 | 71 | 33 | 87 | 40 | 64 |
| 2023 | 382 | 67 | 32 | 85 | 37 | 62 |
| 2022 | 417 | 83 | 35 | 93 | 50 | 68 |
| 2021 | 305 | 51 | 33 | 80 | 43 | 41 |
| 2020 | 300 | 46 | 29 | 77 | 30 | 45 |
| 2019 | 223 | 41 | 36 | 50 | 40 | 37 |
| 2018 | 227 | 39 | 34 | 51 | 41 | 31 |
| 2017 | 209 | 39 | 30 | 50 | 38 | 31 |
| 2016 | 199 | 34 | 34 | 45 | 43 | 24 |
| 2015 | 202 | 35 | 32 | 43 | 45 | 23 |
| Year | Total Assets | Total Liabilities | Total Equity | Total Debt | Net Debt | Cash | Current Assets | Current Liabilities |
|---|---|---|---|---|---|---|---|---|
| 2025 | $3950M | $2615M | $1276M | $1812M | $1618M | $194M | $1109M | $704M |
| 2024 | $4044M | $2585M | $1385M | $1763M | $1532M | $230M | $1070M | $698M |
| 2023 | $4275M | $2735M | $1433M | $1869M | $1646M | $224M | $1176M | $703M |
| 2022 | $4509M | $2975M | $1427M | $1887M | $1656M | $230M | $1313M | $877M |
| 2021 | $2062M | $1135M | $850M | $543M | $147M | $396M | $892M | $476M |
| 2020 | $2043M | $1350M | $643M | $770M | $316M | $454M | $918M | $509M |
| 2019 | $1569M | $830M | $719M | $282M | $123M | $159M | $661M | $446M |
| 2018 | $1480M | $784M | $665M | $275M | $71M | $204M | $645M | $414M |
| 2017 | $1306M | $694M | $588M | $200M | $104M | $96M | $492M | $386M |
| 2016 | $1235M | $684M | $524M | $222M | $137M | $85M | $480M | $390M |
| 2015 | $1188M | $730M | $428M | $290M | $226M | $64M | $464M | $351M |
| Year | Operating CF | Investing CF | Financing CF | CapEx | Free Cash Flow | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| 2025 | $209M | $-101M | $-150M | $-108M | $102M | $-85M | $-52M |
| 2024 | $352M | $-86M | $-259M | $-78M | $274M | $-138M | $-56M |
| 2023 | $163M | $-76M | $-87M | $-83M | $80M | $-16M | $-57M |
| 2022 | $-12M | $-1172M | $1040M | $-95M | $-107M | $-16M | $-54M |
| 2021 | $332M | $-60M | $-348M | $-60M | $272M | $-1M | $-34M |
| 2020 | $222M | $-168M | $244M | $-69M | $153M | $-27M | $-36M |
| 2019 | $216M | $-165M | $-92M | $-91M | $126M | $-48M | $-46M |
| 2018 | $166M | $-63M | $2M | $-71M | $96M | $-46M | $-42M |
| 2017 | $202M | $-116M | $-75M | $-87M | $115M | $-24M | $-39M |
| 2016 | $210M | $-81M | $-106M | $-85M | $125M | $-14M | $-35M |
| 2015 | $168M | $-214M | $7M | $-64M | $104M | $-4M | $-33M |
This report is generated by Finexus and is provided for informational purposes only. It does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any security.
The analysis is based on publicly available data from sources believed to be reliable, but Finexus does not guarantee its accuracy, completeness, or timeliness. Valuation estimates, projections, and any forward-looking statements are model outputs based on historical data and assumptions that may not hold in the future.
Past performance is not indicative of future results. Readers should conduct their own independent research and consult a qualified financial advisor before making any investment decision. Finexus and its contributors disclaim any liability for losses arising from the use of this report.
Created 2026-06-07 · finexus.net